RxDoctor Payments Data

Jeffrey Klassen, MD

Orthopaedic Surgery · Crosby, MNNPI 1114951738

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (48.8%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Steris Corporation at 30.7% of the total. Reporting peaked in 2022 at $8,272 and has fallen 81.3% since, to $1,545 in 2025.

$15,518in general payments, 2019–2025

Across 78 payments — averaging $198.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Steris Corporation$5K
  • Arthrex$5K
  • Foundation Medical, LLC$2K
  • Johnson & Johnson$1K
  • Gemini Medical LLC$1K
  • Stryker$373
  • plus $632 from 6 others
$64,868in research payments, 2019–2025

Across 7 payments — averaging $9266.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Arthrex$65K

What the payments were for

  • Speaking & faculty fees$3,50023%
  • Travel & lodging$7,56749%
  • Food & beverage$3,25121%
  • Education$1,2008%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Steris Corporation2$4,770
Arthrex20$4,588
Foundation Medical, LLC14$2,233
Johnson & Johnson14$1,476
Gemini Medical LLC10$1,446
Stryker(2 entities)6$373
Anika Therapeutics, Inc.3$214
Zimmer Biomet3$176
Smith+Nephew2$116
Medical Device Business Services, Inc.2$70
Catalyst Orthoscience1$40
Novo Nordisk1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,518 in reported general payments places this provider in the 75th percentile of 533 orthopaedic surgery providers in Minnesota.

See all orthopaedic surgery providers in Minnesota →

Medicare billing

Part B allowed, 2024
$21,776
Medicare patients
39
Services billed
71

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in Crosby

See the full list for Minnesota →

Where these figures come from

Is this you, or does something look wrong? →